Type Here to Get Search Results !

F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy

Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

from NYT > Science https://ift.tt/uZmWq31

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.